Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial

Authors: Benoît Guéry, Francesco Menichetti, Veli-Jukka Anttila, Nicholas Adomakoh, José María Aguado, Karen Bisnauthsing, Areti Georgopali, Simon Goldenberg, Andreas Karas, Gbenga Kazeem, Christopher Longshaw, José Palacios, Oliver A. Cornely, Maria J. G. T. Vehreschild - The Lancet 2017 cited by 219